Targeting Type 2 Pathway in Refractory Dermatitis Herpetiformis: Rapid Response to Dupilumab in a Patient Unable to Receive Dapsone
- DOI
- 10.1111/ijd.70769
- Published
- 2026-10-29
- Container
- International Journal of Dermatology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/ijd.70769,
title = {Targeting Type 2 Pathway in Refractory Dermatitis Herpetiformis: Rapid Response to Dupilumab in a Patient Unable to Receive Dapsone},
author = {Miguel Leal Mérida and Alexandra Perea Polak and María Elena Cornax Martín and Sixto Manuel Nieto Vallejo and Leandro Martínez Pilar},
year = {2026},
journal = {International Journal of Dermatology},
doi = {10.1111/ijd.70769},
url = {https://doi.org/10.1111/ijd.70769}
}RIS
TY - JOUR TI - Targeting Type 2 Pathway in Refractory Dermatitis Herpetiformis: Rapid Response to Dupilumab in a Patient Unable to Receive Dapsone AU - Miguel Leal Mérida AU - Alexandra Perea Polak AU - María Elena Cornax Martín AU - Sixto Manuel Nieto Vallejo AU - Leandro Martínez Pilar PY - 2026 JO - International Journal of Dermatology DO - 10.1111/ijd.70769 UR - https://doi.org/10.1111/ijd.70769 ER -
APA
Mérida, M. L., Polak, A. P., Martín, M. E. C., Vallejo, S. M. N., & Pilar, L. M. (2026). Targeting Type 2 Pathway in Refractory Dermatitis Herpetiformis: Rapid Response to Dupilumab in a Patient Unable to Receive Dapsone. International Journal of Dermatology. https://doi.org/10.1111/ijd.70769
Source records
- crossref · retrieved 2026-11-06T22:23:36.575Z